MICHAEL P. CLARE, MD

Plain English
This study looked at how a training session on sexual health affected the confidence and knowledge of nursing students at Queen's University Belfast. Before the training, many students felt uncomfortable and lacked confidence in discussing sexual health, but after attending the workshop, their comfort levels improved significantly, with confidence increasing from an average score of 30% to over 80%. This is important because it shows that targeted training can help future nurses better assist patients with sexual and reproductive health issues. Who this helps: Patients seeking sexual health support.

Plain English
This study looked at what healthcare professionals need to learn about using Artificial Intelligence (AI) in their work, focusing on how current education programs can be improved. Researchers found that HCPs need better training, including a long-term curriculum on AI, hands-on learning experiences, and teamwork in designing the programs. These findings highlight the importance of preparing HCPs for a future where AI plays a significant role in patient care. Who this helps: This benefits healthcare professionals and ultimately improves patient care.

Plain English
This study looked at how a program called Citizens Advice on Prescription helps improve mental health by providing financial advice through health services. The findings showed that the program led to a 20% reduction in antidepressant prescriptions and fewer mental health emergencies, meaning people needed to visit doctors or emergency rooms less often. This is important because it not only improves mental well-being but also saves money for health services. Who this helps: Patients struggling with mental health issues and financial insecurity.

Plain English
This research focuses on the problem of plastic waste, which affects environments from the polar ice caps to the deep ocean. It emphasizes the need to understand where plastic particles end up, how they move, and their harmful effects on ecosystems and human health. The paper highlights various methods and areas of study that can help with these challenges, moving towards finding effective solutions to plastic pollution. Who this helps: This helps environmental scientists, policymakers, and communities affected by plastic pollution.

Plain English
This study looked at how patients feel about the use of artificial intelligence (AI) in health care and what skills they think health care workers should have to effectively use this technology. The researchers interviewed 12 patients and found that 67% were from urban areas and many felt comfortable with technology. They identified three main themes: the importance of building trust with patients, encouraging patient participation, and ensuring proper handling of data relating to AI use. Who this helps: This research benefits patients by emphasizing their role in shaping the future of AI in health care.

Plain English
This study focused on how a type of yeast called Pichia pastoris is used to produce important proteins found in cell membranes, which are key to many functions in the body. Researchers highlighted its advantages, such as being fast and inexpensive, while also being able to modify the proteins as needed. They showcased recent successes in creating various human and animal proteins, demonstrating the yeast's effectiveness in this area. Who this helps: This helps scientists and researchers working on drug development and understanding diseases.

Plain English
This study looks at how to better integrate artificial intelligence (AI) into health care by improving the skills and knowledge of health care providers. Researchers found that there are 24 accredited AI training programs for health care professionals, with topics covering everything from the basics of AI to ethical considerations and practical applications. This is important because equipping providers with the right tools and education can lead to better patient care and more efficient health practices. Who this helps: This benefits health care providers and ultimately patients who receive improved care through enhanced AI use.

Plain English
This research looked at education programs that teach healthcare professionals about artificial intelligence (AI) and how to use it in their work. Out of over 10,000 studies checked, only 41 were relevant, with 10 of those detailing unique training programs about AI and its use in medicine. This matters because as AI becomes more common in healthcare, it’s essential for doctors and nurses to understand it to improve patient care and outcomes. Who this helps: This helps healthcare professionals and ultimately benefits patients receiving care.

Plain English
This study looked at a protein called CD81, which plays a role in how certain viruses infect cells. Researchers found that when they used a special method to extract CD81 from yeast, it formed two distinct groups, and only one of these groups was capable of binding to a protein from the hepatitis C virus, known as E2. This research is important because it opens up new ways to understand how CD81 works with lipids, which can help in developing treatments for infections caused by viruses like hepatitis C. Who this helps: This helps researchers and doctors working on viral infections and potential treatments.

Plain English
This study looked at new compounds that could fight bacteria by targeting a specific enzyme in Burkholderia pseudomallei, the bacteria that causes Whitmore's disease. The researchers created several compounds designed to bind to this enzyme and found that they had antibacterial effects and helped stabilize the enzyme's structure. One particular compound was able to bind effectively, indicating it could be a good candidate for further development. Who this helps: This research benefits patients with Whitmore's disease and healthcare providers by identifying potential new treatments.

Plain English
This study looked at how the feed efficiency (how well cattle turn feed into body mass) is influenced by the cattle's genetics and gender. Researchers tested 52 heifers and bulls and found that those categorized as high feed inefficient consumed about 10-15% more feed than their low feed-efficient counterparts. Importantly, heifers showed higher expression of certain important genes related to energy metabolism compared to bulls, meaning they can process glucose better. Who this helps: This research benefits cattle farmers by identifying traits that can lead to more efficient beef production.

Plain English
This research paper looks at how scientists can successfully produce membrane proteins using yeast, which has been difficult in the past. Recently, there’s been a significant increase in the number of membrane protein structures available for study, indicating that new methods are effective. These advancements are important because understanding these proteins can lead to better drug development and treatment options. Who this helps: This benefits researchers and pharmaceutical companies working on new therapies.

Plain English
This study focused on treating patients with improperly healed fractures of the heel bone, known as calcaneal malunions. Researchers found that restoring the proper alignment of these fractures is effective, especially when done soon after the injury, which makes later surgeries easier and less severe. This is important because fixing these fractures properly can improve patients' foot function and reduce pain. Who this helps: Patients with malunited calcaneal fractures.

Plain English
This study looked at how a protein called irisin affects fat cells taken from human tissue. The researchers found that irisin can help transform regular fat cells into more active "brown" fat cells, increasing the cells' ability to burn energy. Specifically, they discovered that irisin boosted a protein called UCP1, which is involved in energy burning, and it also reduced the creation of new fat cells while encouraging the formation of bone cells. This is important because it suggests that irisin might be useful in treating obesity and promoting bone health. Who this helps: This helps patients struggling with obesity and those needing improved bone health.

Plain English
This study focused on a drug called altiratinib that targets several key processes in cancer growth and resistance to treatment. Researchers found that altiratinib effectively stops tumor growth and spread by blocking important proteins involved in these processes, showing strong results both in lab tests and in live subjects. Importantly, altiratinib can be taken by mouth and can reach the brain, making it a promising option for treating brain tumors. Who this helps: This benefits cancer patients, especially those with brain tumors or those who experience treatment resistance.

Plain English
This study looked at a rare condition called Brown-Sequard syndrome (BSS) that can occur due to issues with the cervical spine, specifically from a calcified herniated disc in the neck. The case reported shows that a long-standing neck problem caused BSS, which is unusual since most previous cases were linked to sudden injuries. The findings emphasize the importance of quickly diagnosing and treating such conditions to prevent further complications. Who this helps: This helps patients with cervical spine disorders and their doctors.

Plain English
This study examined how well the yeast Pichia pastoris produces specific proteins both before and after being prompted to start production. Researchers discovered that functional proteins, such as the human A(2a) adenosine receptor and green fluorescent protein, were produced in bioreactors during the initial growth phase without the need for methanol. In fact, the proteins were produced even when other substances like glucose were used, which typically suppress protein production. Who this helps: This benefits researchers and companies developing new drugs and therapies that rely on these proteins for studying biological processes.

Plain English
This research focused on producing and studying a protein called claudin-1, which is important for understanding how the hepatitis C virus infects liver cells. The scientists were able to create and purify claudin-1 in several forms, but found that it did not bind to a viral protein as expected. This research is significant because it sets the stage for further study of how claudin-1 interacts with other proteins, which could help in developing treatments for hepatitis C. Who this helps: Patients at risk of hepatitis C infection.

Plain English
This research studied how certain compounds, called cytidine derivatives, can inhibit an enzyme known as IspF in the bacteria Burkholderia pseudomallei, which is responsible for serious infections. The researchers created and tested a series of these compounds and found one that binds to the enzyme just as effectively as a well-known compound, with specific binding characteristics. Understanding how these molecules work is important as it could lead to the development of new treatments for infections caused by this bacteria. Who this helps: This research benefits patients suffering from infections caused by Burkholderia pseudomallei.

Plain English
The study focused on finding substances that can block a specific enzyme, Methionine Aminopeptidase (MetAP), to help fight bacteria that cause serious infections. The researchers discovered that certain chemical compounds, specifically nitroxoline analogs, effectively hinder the growth of the bacteria Burkholderia pseudomallei, with the strongest one operating at a concentration as low as 30 nanomoles. This is important because it identifies new potential treatments for infections that are hard to treat. Who this helps: This benefits patients with serious bacterial infections, especially those caused by Burkholderia pseudomallei.

Plain English
This study focused on using a special tank called a bioreactor to produce proteins in yeast more effectively. Researchers set up a 3-liter bioreactor, which improved the production process, allowing for better control and higher yields. The findings are important because they enable more consistent and efficient protein production, which can be crucial in various medical applications. Who this helps: This benefits patients and doctors by improving the production of important proteins used in treatments.

Plain English
This study explored how low oxygen levels affect heart muscle cells, known as cardiac myoblasts. Researchers found that after just 30 minutes in low oxygen (2%), these cells began to die, and by 4 hours, a specific type of cell death called apoptosis occurred, mainly due to the buildup of harmful molecules called superoxide radicals. This matters because it shows that the damage to heart cells under low oxygen conditions is mostly caused by these radicals rather than a lack of energy. Who this helps: Patients with heart conditions related to low oxygen levels.

Plain English
This study looked at how light behaves inside special tiny structures made of materials that have different properties in different directions. Researchers found that the way light is intensified changes depending on the frequency used, showing specific patterns called standing waves and evanescent modes. This is important because understanding these patterns can lead to better optical devices, even though the light's strength is slightly reduced due to material loss. Who this helps: This benefits researchers and engineers developing advanced optical technologies.

Plain English
This study looked at how yeast cells produce human membrane proteins, which are important for developing new drugs. Researchers found ways to increase the amount of these proteins that yeast can produce effectively, making it easier to gather samples needed for drug research. Their findings could streamline the process of creating new treatments for various diseases. Who this helps: This helps drug developers and researchers working on new medications.

Plain English
Researchers studied a group of chemicals called aminopyridinecarboxamide-based inhibitors to see how well they work against a specific protein involved in inflammation. They found that one particular chemical, 2-amino-5-chloropyridine-4-carboxamide, was the most effective at blocking this protein and showed better activity in cells. This is important because it could lead to new treatments for conditions related to inflammation. Who this helps: This helps patients suffering from inflammatory diseases.

Plain English
This study looked at new materials designed to control how light behaves, focusing on a special type of material called metamaterials with unique properties. Researchers found they could create materials that made light travel slowly at a rate of 29.6, and then also quickly with a rate of -1.1. This is important because it could lead to better technologies for controlling light, which could improve optical devices like sensors and communication tools. Who this helps: This benefits engineers and scientists working on advanced optical technologies.

Plain English
This study looked at a new type of drug that targets an enzyme called p38-alpha kinase, which plays a role in inflammation and cell stress responses. The researchers developed a drug called DP-802 that binds to specific parts of the enzyme, effectively blocking its active form without needing to attach to the usual binding site. They found that DP-802 was particularly effective and selective, preventing the enzyme from becoming active in a way that could contribute to diseases. Who this helps: This benefits patients with inflammatory conditions by offering a more targeted treatment option.

Plain English
Researchers studied a new compound designed to block a specific protein called alpha(v)beta(3), which is involved in cancer growth and abnormal blood vessel formation. They developed a version of this compound that is both strong and targeted, outperforming previous attempts: it effectively inhibits the protein’s function, potentially leading to more effective cancer treatments. This discovery is significant because it may improve ways to control tumor development and treat related conditions. Who this helps: This benefits cancer patients and doctors looking for better treatment options.

Plain English
This study looked at a group of new chemical compounds called 1,2,4-oxadiazoles, which block a specific receptor involved in various diseases. The researchers found that these compounds are very effective at targeting the alpha(v)beta3 receptor while being less active against similar receptors, showing selectivity rates that imply they may work better with fewer side effects. This matters because these compounds could potentially lead to better treatments for diseases like cancer and blood disorders, where this receptor plays a key role. Who this helps: Patients with conditions related to the alpha(v)beta3 receptor.

Plain English
This study looked at how genetic variations in a part of the immune system, called HLA class I alleles, affect liver damage in patients with chronic hepatitis C. Researchers found that patients with certain genetic variations experienced faster progression of liver fibrosis, with those having heterozygous HLA-B alleles progressing at a rate of 0.08 units per year, compared to 0.06 for those without that variation. Understanding these genetic factors can help doctors predict disease severity and tailor treatments for patients. Who this helps: This information benefits patients with chronic hepatitis C and their healthcare providers.

Plain English
Researchers developed a new way to measure the size of the parotid gland, which can grow larger in people with eating disorders like bulimia and anorexia. They used calipers to measure the width of the face in 15 normal individuals, finding that the measurements were consistent and ranged from 9.1 cm to 15.3 cm. This method is important because it's quick, easy to do, and doesn't hurt, making it useful for tracking changes in gland size in patients with eating disorders. Who this helps: Patients with eating disorders and their healthcare providers.

Plain English
This research looked at a new group of compounds designed to block a specific enzyme called IKK-2, which is involved in inflammation. Out of 21 different compounds tested, six were found to significantly reduce the production of an inflammatory substance called IL-8 in cells from patients with rheumatoid arthritis. This matters because lowering IL-8 can help reduce inflammation and improve symptoms for people with this condition. Who this helps: This benefits patients with rheumatoid arthritis.

Plain English
This study looked at how two substances, calcitriol and epidermal growth factor (EGF), work together to help bone-forming cells, called osteoblasts, mature. Researchers found that when they treated human osteoblast cells with both calcitriol (100 nM) and EGF (10 ng/ml), there was a significant increase in important proteins, osteocalcin and alkaline phosphatase, which are markers of cell maturation. This matters because understanding how these substances interact could lead to new strategies for improving bone health. Who this helps: This helps patients with bone diseases and doctors looking for better treatments.

Plain English
Researchers developed new drugs called pyrazinones that can effectively block a specific protein complex linked to blood clotting. One particular compound, called pyrazinone 23, was found to be very effective, with a strength of 16 nanomolar and more than 6,250 times more selective than other similar proteins. This is important because it shows potential for treating blood clots without causing excessive bleeding, which is a common side effect of current treatments. Who this helps: This helps patients at risk of dangerous blood clots, such as those with heart conditions or undergoing surgery.

Plain English
In this study, researchers created new drugs called pyrazinone inhibitors that target a specific protein complex involved in blood clotting, known as the Tissue Factor/Factor VIIa complex. They found that one particular compound, called compound 34, was very effective, working at a concentration of just 16 nanomoles and being over 6,250 times more selective for this target than for other related proteins that are involved in blood clotting. This is important because it could lead to treatments that prevent blood clots without causing harmful bleeding. Who this helps: This helps patients at risk for blood clots, such as those undergoing surgery or with certain heart conditions.

Plain English
This research looked at the genetic factors that might make people in Hong Kong more likely to develop liver cancer (hepatocellular carcinoma or HCC). They studied DNA from 98 HCC patients and several control groups, finding that certain genetic variations related to immune response (specifically IL-1beta and IL-1RN) were much more common in the Chinese population compared to Northern Europeans. Although the study didn't find a direct link between these genetic variations and liver cancer, the differences in these gene types may help explain why liver cancer rates are higher among Chinese people. Who this helps: This information could benefit researchers and doctors working to understand and treat liver cancer in Chinese patients.

Plain English
This study looked at the S65C mutation in people who also carry the C282Y mutation related to iron overload. Among 309 individuals with the C282Y mutation, 12 had the S65C mutation, and five of them showed high levels of iron in their blood, while others had normal levels. These findings highlight that some people with the S65C mutation might experience iron overload, and testing for this mutation could help identify those at risk. Who this helps: This benefits patients with unexplained iron overload and their doctors.

Plain English
This study looked at the genetic factors related to biliary atresia, a serious liver condition in young children. Researchers examined genes linked to the immune system in 101 children with this condition and compared them to 134 healthy adults. They found no significant differences, indicating that the disease is not caused by the genetic variations they studied. Who this helps: This helps doctors and researchers by clarifying that certain genetic factors do not contribute to biliary atresia, guiding them in future investigations.

Plain English
This study looked at specific genetic variations in three cytokine genes (IL-1, IL-10, and TNF-alpha) to see how they relate to the body's ability to fight off hepatitis C virus (HCV) infection on its own or in response to treatment. Researchers analyzed DNA from two large groups of people and found no significant differences in these genetic variations between those who cleared the virus naturally and those who responded to treatment. The results suggest that other genes may be more important in determining how individuals respond to HCV infection. Who this helps: This helps researchers identify potential targets for better treatments for hepatitis C.

Plain English
This study looked at genetic factors that might make people more or less likely to develop primary sclerosing cholangitis (PSC), a liver disease. Researchers found that the MICA*002 allele appears to protect against PSC, as it was present in only 6.4% of patients compared to 35% of healthy controls. On the other hand, the MICA*008 allele was more common in PSC patients at 66% versus 48% in controls, indicating it may increase the risk of the disease, especially if an individual has two copies of it. Who this helps: This research helps patients at risk for PSC by providing insights into genetic factors that influence their condition.

Plain English
This study looked at jaundice caused by the antibiotic co-amoxiclav, focusing on how it shows up in patients and its possible genetic links. Researchers found 22 cases, mostly in older adults, with jaundice appearing an average of 17 days after starting the drug. The bilirubin levels, which indicate liver function, peaked at 225 micromol/l, and jaundice lasted about 69 days on average. A specific gene variant, DRB1*1501, was found in 70% of the jaundice patients, suggesting a possible genetic risk factor for this reaction. Who this helps: This research helps patients taking co-amoxiclav and doctors prescribing it, especially those concerned about liver health.

Plain English
This study looked at how variations in certain genes related to immune response are linked to the severity and treatment outcomes of type 1 autoimmune hepatitis. It found that a specific genetic variation (called a polymorphism) in the tumor necrosis factor gene was present in 56% of patients compared to 26% of healthy individuals. Patients with this genetic variation responded poorly to corticosteroids, with only 56% entering remission compared to 78% of those without the variation, highlighting that genetics can influence treatment success. Who this helps: Patients with type 1 autoimmune hepatitis.

Plain English
This study looked at specific genetic variations related to type 1 autoimmune hepatitis (AIH), focusing on certain cytokine genes that may influence the disease. Researchers found that a specific variant called TNF*2 was present in 49% of AIH patients compared to 34% of healthy controls, highlighting a significant association. This matters because it suggests that multiple genetic factors, not just one, contribute to the likelihood of developing type 1 AIH. Who this helps: Patients with type 1 autoimmune hepatitis and their doctors.

Plain English
This study looked at how Bristol Regional Medical Center (BRMC) improved their hospital profits by using a structured approach to care for patients with simple pneumonia and pleurisy. By using data to develop new treatment plans, they were able to cut costs significantly while maintaining high-quality care, showing promising results. The hospital not only saved money, but this approach also positively affected care for other conditions. Who this helps: This helps patients by ensuring they receive effective care without unnecessary costs.

Plain English
Researchers studied a new drug called SC-52151, designed to inhibit the HIV protease, which is crucial for the virus to replicate. They found that SC-52151 effectively reduced the amount of HIV in the body at very low doses (around 26 ng/ml) and worked well in combination with other treatments without increasing toxicity. This is important because it means that SC-52151 could provide a new way to treat HIV more effectively and safely. Who this helps: This benefits patients living with HIV by offering a potential new treatment option.

Plain English
Researchers studied new versions of a pain-relieving molecule based on enkephalin to see how changes in its structure affect its ability to work as a medicine. They found that even small changes in certain parts of the molecule can significantly reduce how well it binds to the pain receptors. This is important because it helps scientists design more effective pain medications in the future. Who this helps: This helps patients suffering from chronic pain.

Plain English
This research focused on a new renin inhibitor called SC-51106, which was crafted to interact with the human renin protein, a key player in blood pressure regulation. The study uncovered a novel binding site near another important site on the protein, enhancing our understanding of how these types of inhibitors work. This finding is significant because it opens up new possibilities for developing more effective blood pressure medications. Who this helps: This benefits patients with high blood pressure and the doctors treating them.